Share on

Global Single-Cell Analysis Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Cells (Human Cells, Animal Cells and Microbial Cells), Products, Technique, Application and Region – Industry Forecast (2022 to 2027).

Published: January, 2022
ID: 2653
Pages: 182
Formats: report pdf report excel report power bi report ppt

Single-Cell Analysis Market Size (2022 to 2027)

As per our report, the global single-cell analysis market size is estimated to be worth USD 4.85 billion by 2027 and USD 2.26 billion in 2022, growing at a CAGR of 16.5% during the forecast period.

In cellular biology, single-cell analysis consists of the study of genomics, proteomics, metabolomics, and so on. Due to the vast differences seen between cells, both prokaryotes and eukaryotes analysing single cells make it possible to unveil the mechanisms that could not be seen otherwise. Modern innovations such as Fluorescence-Activated Cell Sorting have increased the efficiency of cell sorting. Other technological advances are increasing our chances to sequence the genome and transcriptome. The applications of studying the genome at a single-cell level include tracking the changes that occur in bacteria and exploring the genetic evolution of cancer. Additional research today in the area has helped biologists to learn more about gene expression profiles in individual cells.

Impact of COVID-19 on the global single-cell analysis market:

The coronavirus (COVID-19) is the most significant public health emergency causing terrible outcomes across many countries. The unpredicted eruption of the COVID-19 impact has cleared the world representing the medical challenges associated with treating it as an unknown disease. The National governments are working hard with the pharmaceutical companies and institutions in providing efficient treatment for those suffering from the infection. The single-cell analysis is obtaining significance during the pandemic crisis. As per the American Journal of Physiology-Lung Cellular and Molecular Physiology, single-cell analysis over mass cytometry by time-of-flight (CyTOF) was used to study the peripheral blood changes mononuclear cell profiles of COVID-19 infected patients. The continuous research activities by feeling the application of single-cell analysis method in the COVID virus. The single-cell analysis market provides good opportunities throughout the pandemic period. According to the article published in Cell, 2021, implemented single-cell RNA sequencing on 284 samples of COVID 19 infected patients and has created a resistant situation with 1.46 million cells, permitting the estimation and relation amid various peripheral immune subtype modifications with varied clinical features like age, sex, criticality and disease stages of COVID 19.

MARKET DRIVERS:

The significant factors favoring the single-cell analysis market growth include the increasing geriatric population, high prevalence of infectious diseases, and the growing demand for personalized medication.

As the health problems in the world faces continue to rise, the need for research to develop better and effective medicines also increases. Along with the technological advancements in single-cell analysis products, it is expected to drive the market forward.

Widening single-cell analysis applications in genomics, transcriptomics, proteomics, and epigenetic studies further boost the market growth. Similarly, big players invest in R & D to evaluate single-cell analysis applications in stem cell transplant procedures to improve these processes' success rates.

The advent of advanced devices that allow secure procedures for transcriptomics and proteomics causes the adoption of single-cell analysis techniques. Over the forecast period, government marketing schemes and measures like Health Japan 21 and Germany's Preventive Health Care Act are expected to fuel market growth. Factors such as the high prevalence of neurological disorders and the increase in disease incidence also drive market growth.

MARKET RESTRAINTS:

Factors that are significantly hindering the growth of the global single-cell analysis market are the high costs associated, restricted healthcare reimbursement policies, and concerns related to intellectual property rights. Moreover, growing competition for new entries into the market obstructs the single-cell analysis market growth during the forecast period.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021 to 2027

Base Year

2021

Forecast Period

2022 to 2027

Segments Covered

By Cell Type, Technique, Application, End-User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the global single-cell analysis market has been segmented based on the cell type, technique, application, end-user, and region.

Single-Cell Analysis Market - By Cell Type:

  • Human
  • Animal
  • Microbial

Based on cell type, the class of human cells had the largest market share in the global market in 2020 and is projected to grow as fast as possible throughout the forecast period. It would be due to the rising prevalence of infectious diseases in the geriatric population and stem cell research funding.

Single-Cell Analysis Market - By Technique:

The flow cytometry segment is expected to lead the market during the forecast period based on the technique. It is due to the broad usage of flow cytometry in identifying and measuring the physical and chemical characteristics of the population of cells or particles. 

Simultaneously, the NGS segment is anticipated to have the highest growth rate during the review period because of the increasing applications among the products in drug discovery for cancer and other constant and continuous diseases propelling the single-cell analysis growth period.

Single-Cell Analysis Market - By Application:

  • Research Applications
    • Cancer Research
    • Immunology Research
    • Neurology Research
    • Stem Cell Research
    • Other Research Applications
  • Medical Application
  • Non-invasive Prenatal Diagnosis
  • In Vitro Fertilization
  • Circulating Tumor Cell Detection

Based on the application, the research applications segment held a larger market share during the historical period. Due to increased funds availability, this class is further expected to maintain its dominance during the forecast period.

Single-Cell Analysis Market - By End User:

  • Academic and Research Laboratories
  • Biotechnology and Pharmaceutical Companies
  • Hospital and Diagnostic Laboratories

Based on the end-user, the Hospitals and diagnostic laboratories segment is expected to dominate during the forecast period due to continuous efforts to cover the gap for implementing OMICs technology from the research laboratories to clinical settings. These hospitals provide high-quality diagnostic care and a safe environment for patients.

Single-Cell Analysis Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Regionally, the global single-cell analysis market was dominated by North America in 2019, with the region accounting for 37% of the overall market share. North America was followed next in line by Europe and Asia-Pacific.

North America is expected to dominate the global single-cell analysis market over the forecast period. Existing application of cell analysis in drug discovery, growing elderly people population, and continuous development in single-cell analysis fuels the market growth over the forecast period. U.S. is dominating the market due to developments in modern therapeutics like IVF, and parenteral screening drives the U.S. market. Canada is followed after the U.S. due to the standard increase of chronic diseases that propels the growth.

Europe is expected to lead the second-largest market in the single-cell analysis over the analysis period after North America due to increasing consumer awareness regarding advanced technologies, growing research, and development activities. The U.K. is leading the market due to increasing expenditure is fuelling the growth. Germany is expected to have speed growth after the U.K. due to the increasing occurrence rate of infectious diseases.

Asia-Pacific is expected to overgrow in the coming years, as evidenced by the high CAGR value for the region. China is dominating the cell analysis market and is expected to continue its growth due to the increasing elder people population. India is estimated to have noticeable and considerable growth over the analysis period due to increasing biotechnology and pharmaceutical companies.

Another promising area for the market in Latin America is expected to show high growth rates in the coming years. It is due to the growing large number of producing proteins, development of cell lines. Brazil is expected to have the largest share in the market due to growing healthcare expenditure and increasing patient population.

Middle East & Africa is considered to have a slight inclination in the growth rate due to advanced therapies for cancer treatment. 

KEY MARKET PARTICIPANTS:

Some of the prominent companies leading the global single-cell analysis market profiled in the report are Merck KGaA, Becton, Dickinson and Company, Promega Corporation, Danaher Corporation, General ElectricCompany, Thermo Fisher Scientific, Miltenyi Biotec, Illumina, Bio-Rad Laboratories, Fluidigm Corporation, NanoString Technologies, Agilent Technologies, Abcam Plc, NuGEN Technologies Inc., LumaCyte, PluriSelect Life Science UG & Co. KG, Sysmex Partec, Bio-Techne Corporation, Promega Corporation, 10x Genomics, WaferGen Bio-systems, Bruker, and Fluxion Bioscience.

RECENT MARKET DEVELOPMENTS:

  • In July 2020, 10X Genomics launched its chromium single-cell immunity profiling V2 product. This new product enlarges the initial version's abilities, assisting fundamental breakthroughs in immunology, oncology, autoimmunity, inflammation, and infectious diseases. The V2 product offers a thorough approach to test the cellular heterogeneity of the immune system T and B cells concurrently. 
  • In June 2019, Beckman Coulter Life Sciences made a public statement regarding the obtainment of Cytobank, a single-cell data analysis. The Cytobank platform boosts research manufacturing by allowing structured high-dimensional data analysis and collaboration across the globe. 
  • In April 2020, Bio-Rad Laboratories announced that it had obtained Celsee Inc., which provides a scalable, practical, and efficient approach to identify single cells. The system can layer thousands to millions of cells for genomic and proteomic applications.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: sales@marketdataforecast.com

Click for Request Sample